Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Price Passes A

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $5.46 and traded as high as $5.89. Merrimack Pharmaceuticals shares last traded at $5.68, with a volume of 7,552 shares. Separately, StockNews.com started coverage on Merrimack Pharmaceuticals […]

Related Keywords

Radnor , Powys , United Kingdom , Cambridge , Cambridgeshire , Massachusetts , United States , Garyl Crocker , , Radnor Capital Management , Securities Exchange Commission , Merrimack Pharmaceuticals , Yakira Capital Management Inc , Nasdaq , Merrimack Pharmaceuticals Company Profile , Bronte Capital Management Pty Ltd , Merrimack Pharmaceuticals Inc , Get Rating , Exchange Commission , Director Noah , Capital Management , Bronte Capital Management Pty , Capital Management Pty , Pharmaceuticals Company Profile , Nasdaq Mack , Smack , Medical , 59032810 , Stocks , Technicals ,